Frank A. Finnerty

3.1k total citations
110 papers, 2.2k citations indexed

About

Frank A. Finnerty is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Frank A. Finnerty has authored 110 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cardiology and Cardiovascular Medicine, 15 papers in Pulmonary and Respiratory Medicine and 13 papers in Surgery. Recurrent topics in Frank A. Finnerty's work include Blood Pressure and Hypertension Studies (31 papers), Hormonal Regulation and Hypertension (10 papers) and Pregnancy and preeclampsia studies (7 papers). Frank A. Finnerty is often cited by papers focused on Blood Pressure and Hypertension Studies (31 papers), Hormonal Regulation and Hypertension (10 papers) and Pregnancy and preeclampsia studies (7 papers). Frank A. Finnerty collaborates with scholars based in United States, Sweden and Switzerland. Frank A. Finnerty's co-authors include Michael Davidov, Joseph F. Fazekas, William J. Mroczek, Lloyd B. Witkin, J. Tuckman, Lawrence Shaw, C. K. Himmelsbach, Edward D. Freis, J. Buchholz and John C. Rose and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Frank A. Finnerty

105 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank A. Finnerty United States 27 817 341 313 247 221 110 2.2k
Marvin Moser United States 27 1.3k 1.6× 369 1.1× 182 0.6× 555 2.2× 105 0.5× 154 2.3k
Walter M. Kirkendall United States 23 886 1.1× 376 1.1× 275 0.9× 371 1.5× 47 0.2× 76 2.1k
D G Beevers United Kingdom 33 1.6k 1.9× 410 1.2× 310 1.0× 647 2.6× 130 0.6× 145 3.4k
C J Bulpitt United Kingdom 29 979 1.2× 207 0.6× 181 0.6× 475 1.9× 81 0.4× 97 2.8k
DG Beevers United Kingdom 23 982 1.2× 183 0.5× 225 0.7× 284 1.1× 128 0.6× 60 2.1k
J Jervell Norway 27 704 0.9× 438 1.3× 149 0.5× 1.5k 5.9× 169 0.8× 97 3.0k
M J Klag United States 20 819 1.0× 367 1.1× 632 2.0× 186 0.8× 259 1.2× 24 3.2k
Herbert G. Langford United States 31 1.4k 1.7× 398 1.2× 256 0.8× 605 2.4× 46 0.2× 98 3.3k
Gordon S. Stokes Australia 26 805 1.0× 237 0.7× 248 0.8× 422 1.7× 38 0.2× 130 2.0k
E. B. Raftery United Kingdom 22 2.0k 2.4× 644 1.9× 225 0.7× 205 0.8× 61 0.3× 108 2.9k

Countries citing papers authored by Frank A. Finnerty

Since Specialization
Citations

This map shows the geographic impact of Frank A. Finnerty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank A. Finnerty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank A. Finnerty more than expected).

Fields of papers citing papers by Frank A. Finnerty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank A. Finnerty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank A. Finnerty. The network helps show where Frank A. Finnerty may publish in the future.

Co-authorship network of co-authors of Frank A. Finnerty

This figure shows the co-authorship network connecting the top 25 collaborators of Frank A. Finnerty. A scholar is included among the top collaborators of Frank A. Finnerty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank A. Finnerty. Frank A. Finnerty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Materson, Barry J., et al.. (1986). A multicenter, randomized, double-blind dose-response evaluation of step-2 guanfacine versus placebo in mild to moderate hypertension. The American Journal of Cardiology. 57(9). E32–E37. 7 indexed citations
2.
Finnerty, Frank A.. (1975). The Nurse's Role in Treating Hypertension. New England Journal of Medicine. 293(2). 93–94. 13 indexed citations
3.
Lee, W. Robert, William J. Mroczek, Michael Davidov, & Frank A. Finnerty. (1975). Nonemergency use of slow infusions of diazoxide. Clinical Pharmacology & Therapeutics. 18(2). 154–157. 8 indexed citations
4.
Finnerty, Frank A.. (1975). Extensive hypertensive work-up. In rebuttal to Dr. Melby. JAMA. 231(4). 405–405. 1 indexed citations
5.
Finnerty, Frank A.. (1974). Hypertension as a clinical problem. Preventive Medicine. 3(3). 323–327.
6.
Finnerty, Frank A.. (1971). Relationship of extracellular fluid volume to the development of drug resistance in the hypertensive patient. American Heart Journal. 81(4). 563–565. 46 indexed citations
7.
Finnerty, Frank A., et al.. (1968). Relation of Sodium Balance to Arterial Pressure During Drug-Induced Saluresis. Circulation. 37(2). 175–183. 20 indexed citations
8.
Davidov, Michael, et al.. (1967). The antihypertensive effects of an imidazoline compound. Clinical Pharmacology & Therapeutics. 8(6). 810–816. 50 indexed citations
9.
Finnerty, Frank A.. (1966). TREATMENT OF MILD TOXEMIA. Clinical Obstetrics & Gynecology. 9(4). 944–953. 3 indexed citations
10.
Finnerty, Frank A., et al.. (1963). Clinical Evaluation of Diazoxide. Circulation. 28(2). 203–208. 73 indexed citations
11.
Finnerty, Frank A.. (1962). Hemodynamics of Angiotensin in Man. Circulation. 25(1). 255–258. 34 indexed citations
12.
Finnerty, Frank A., et al.. (1962). Preliminary Observations on the Value of Diazoxide Administered Intravenously in Man. Angiology. 13(11). 541–544. 9 indexed citations
13.
Finnerty, Frank A., et al.. (1959). Correlation of Heart Rate During Norepinephrine Infusion with Pulse Pressure Following Amyl Nitrite Inhalation. Circulation. 20(4). 569–573. 1 indexed citations
14.
Finnerty, Frank A., J. Buchholz, J. Tuckman, George Hajjar, & G. D. Massaro. (1959). Evaluation of Chlorothiazide Alone in the Treatment of Moderately Severe and Severe Hypertension. Circulation. 20(6). 1037–1042. 9 indexed citations
15.
Finnerty, Frank A., et al.. (1958). THE BLOOD VOLUMES AND PLASMA PROTEIN DURING LEVARTERENOL-INDUCED HYPERTENSION1. Journal of Clinical Investigation. 37(3). 425–429. 86 indexed citations
16.
Finnerty, Frank A.. (1956). PYELONEPHRITIS MASQUERADING AS TOXEMIA OF PREGNANCY. Journal of the American Medical Association. 161(3). 210–210. 13 indexed citations
17.
Finnerty, Frank A., et al.. (1954). Cerebral hemodynamics in acute hypotension. The American Journal of Medicine. 16(4). 592–593. 3 indexed citations
18.
Finnerty, Frank A., Lloyd B. Witkin, & Joseph F. Fazekas. (1954). Cerebral Hemodynamics during Cerebral Ischemia Induced by Acute Hypotension1. Journal of Clinical Investigation. 33(9). 1227–1232. 196 indexed citations
19.
Finnerty, Frank A.. (1953). Comparison of Hypotensive and Emetic Dosages of Cryptenamine and Other Veratrum Extracts in Humans.. Experimental Biology and Medicine. 84(2). 379–380. 4 indexed citations
20.
Finnerty, Frank A. & George J. Fuchs. (1953). The Veratrum Treatment of Toxemia of Pregnancy: A Controlled Study. American Journal of Obstetrics and Gynecology. 66(4). 830–841. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026